10Y annualized return is
positive but below market average
at 5.7% per year
RVTY has met or exceeded earnings expectations in
the majority of
recent quarters (8/10)
Reasonable Price-to-Book Ratio
Strong Gross Profit Margin
High Price-to-Earnings Ratio
Elevated Price-to-Sales Ratio
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Overall, Revvity presents a strong business model with solid financial performance and a competitive position in the Life Sciences sector. However, challenges in instrumentation and uncertainties in market conditions warrant cautious optimism regarding future growth prospects.
Analysis Date: January 31, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Revvity, Inc. is a company that helps scientists and doctors by providing tools and services for medical testing and research. They create instruments and software that allow for the early detection of diseases and genetic disorders, like Down syndrome and infections. Revvity also offers solutions for studying the environment, such as testing air and water quality. Overall, their work supports healthcare, agriculture, and research to improve people's health and safety.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect RVTY's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact RVTY's performance.
Access Full Risk AnalysisTrailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights
